Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$246K Buy
2,081
+81
+4% +$9.35K 0.02% 292
2026
Q1
$239K Hold
2,000
0.02% 263
2025
Q4
$272K Hold
2,000
0.02% 242
2025
Q3
$295K Hold
2,000
0.02% 243
2025
Q2
$259K Sell
2,000
-1,064
-35% -$129K 0.02% 246
2025
Q1
$366K Sell
3,064
-753
-20% -$93.3K 0.04% 194
2024
Q4
$443K Buy
3,817
+141
+4% +$17.8K 0.04% 152
2024
Q3
$447K Buy
3,676
+2,000
+119% +$268K 0.04% 164
2024
Q2
$227K Buy
+1,676
New +$228K 0.03% 226

Other funds holding XYL

LRI Investments's XYL Position: Q2 2026 in Review

LRI Investments increased its Xylem (XYL) stake by 4.1% in Q2 2026, buying an estimated $9.35K and bringing the position to 2,081 shares worth $246K. The position accounts for 0.02% of the portfolio, ranked #292.

LRI Investments first reported a position in XYL in Q2 2024 and has held it in 9 quarters since. The position peaked at $447K in Q3 2024. 431 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • LRI Investments held 2,081 shares of Xylem worth $246K as of Q2 2026.
  • LRI Investments bought 81 Xylem shares in Q2 2026, an estimated $9.35K.
  • Xylem made up 0.02% of LRI Investments's portfolio in Q2 2026, its #292 holding.
  • LRI Investments first reported a position in Xylem in Q2 2024 and has held it in 9 quarters since.
  • LRI Investments's Xylem position peaked at $447K in Q3 2024.
  • 431 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.